Literature DB >> 3143891

Purification and immunological characterization of neuraminidase produced by Streptococcus pneumoniae.

R A Lock1, J C Paton, D Hansman.   

Abstract

Previous workers have suggested that Streptococcus pneumoniae, the pneumococcus, produces multiple forms of the enzyme neuraminidase. By serial chromatography on DEAE-cellulose, Sephacryl S-200, Amicon Red-A gel and hydroxylapatite we have purified to electrophoretic homogeneity a pneumococcal neuraminidase with an apparent molecular weight of 86,000 (as determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis). Mouse antiserum raised against the purified material reacted with a single species with molecular weight 107,000 (107K form) in crude pneumococcal cell lysate. During the purification procedure this species was progressively degraded to the molecular weight 86,000 (86K) form whilst retaining enzyme activity. Degradation of neuraminidase was inhibited by phenylmethylsulphonylfluoride (PMSF) and ethylenediaminetetraacetic acid (EDTA). Purification of the enzyme in the presence of these protease inhibitors permitted the isolation of the 107K species substantially undegraded and greater than 98% pure. Our findings on the degradation of neuraminidase during its purification account for previous reports of multiple neuraminidase isoenzymes in Streptococcus pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143891     DOI: 10.1016/0882-4010(88)90046-0

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  23 in total

1.  Sialic acid transport contributes to pneumococcal colonization.

Authors:  Carolyn Marion; Amanda M Burnaugh; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

2.  Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli.

Authors:  M Camara; T J Mitchell; P W Andrew; G J Boulnois
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Western blot analysis of immunoglobulin G antibodies to pneumococcal protein antigens in healthy adults.

Authors:  J Renneberg; M Svinhufvud; K Prellner; P Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

4.  Free Sialic Acid Acts as a Signal That Promotes Streptococcus pneumoniae Invasion of Nasal Tissue and Nonhematogenous Invasion of the Central Nervous System.

Authors:  Brandon L Hatcher; Joanetha Y Hale; David E Briles
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A.

Authors:  Mamie T Coats; Trudy Murphy; James C Paton; Barry Gray; David E Briles
Journal:  Microb Pathog       Date:  2011-03-04       Impact factor: 3.738

6.  Slipped-Strand Mispairing in the Gene Encoding Sialidase NanH3 in Gardnerella spp.

Authors:  Shakya P Kurukulasuriya; Mo H Patterson; Janet E Hill
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

7.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

8.  Cloning, expression, and characterization of a neuraminidase gene from Arcanobacterium pyogenes.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

9.  A neuraminidase from Streptococcus pneumoniae has the features of a surface protein.

Authors:  M Cámara; G J Boulnois; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.